Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8654004 | 0.86 | HPGD (0.50) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL1070520 | 0.73 | CYP3A4 (0.77) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL2786303 | 0.71 | HPGD (0.55) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL8651084 | 0.70 | HPGD (0.40) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL12521788 | 0.63 | CYP3A4 (0.75) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL12521810 | 0.60 | CYP3A4 (0.61) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| SCHEMBL11088249 | 0.60 | CYP3A4 (0.79) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| Ciglitazone SCHEMBL20125581 | 0.59 | HPGD (1.00) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| Ciglitazone SCHEMBL38185 | 0.59 | HPGD (1.00) | HPGDMEN1ALDH1A1TP53CYP1A2 | |
| Ciglitazone SCHEMBL20125576 | 0.59 | HPGD (1.00) | HPGDMEN1ALDH1A1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5814647-A | ANTICARCINOGENIC AGENTS, ANTIDIABETIC AGENTS AND MENSTRUAL DISORDERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-09-29 | — | — | US | claimed |
| US-5708012-A | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus | SANKYO COMPANY, LIMITED (JP) | 1998-01-13 | — | — | US | claimed |
| US-5814647-A | ANTICARCINOGENIC AGENTS, ANTIDIABETIC AGENTS AND MENSTRUAL DISORDERS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1998-09-29 | — | — | US | disclosed |
| US-5708012-A | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus | SANKYO COMPANY, LIMITED (JP) | 1998-01-13 | — | — | US | disclosed |